By Josh White
Date: Monday 08 Dec 2025
(Sharecast News) - Proteome Sciences announced on Monday that it has secured a third contract from a US biopharmaceutical client for its mass spectrometry services, further expanding the company's role in supporting clinical development programmes.
By Josh White
Date: Friday 21 Feb 2025
(Sharecast News) - Proteome Sciences announced on Friday that it has secured a contract worth over $1m from a US biopharmaceutical company for the use of its mass spectrometry services in an ongoing clinical trial.
By Benjamin Chiou
Date: Monday 23 Dec 2024
(Sharecast News) - Shares in drug development services group Proteome Sciences rose on Monday after the company said 2024 results should reflect a good recovery and that its pipeline is looking strong for next year.
| Currency | UK Pounds |
| Share Price | 1.60p |
| Change Today | 0.100p |
| % Change | 6.67 % |
| 52 Week High | 3.60p |
| 52 Week Low | 1.28p |
| Volume | 17,740 |
| Shares Issued | 350.72m |
| Market Cap | £5.61m |
| RiskGrade | 353 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:48 | 1,306 @ 1.46p |
| 14:48 | 80 @ 1.46p |
| 13:00 | 6,261 @ 1.60p |
| 10:30 | 1,694 @ 1.45p |
| 10:30 | 1,506 @ 1.45p |
You are here: research